How much is TARA Biosystems worth in 2026?

TARA Biosystems has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has TARA Biosystems raised?

TARA Biosystems has raised N/A in total funding across 1 funding rounds.

TARA Biosystems

Drug Discovery

TARA Biosystems valuation and funding history | Last updated: April 18, 2017 | 1 funding rounds

Current Valuation

N/A

As of April 18, 2017

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Apr 2017

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 18, 2017	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

TARA Biosystems is currently valued at N/A as of April 18, 2017.

Track TARA Biosystems Valuation Updates

Get notified when TARA Biosystems raises new funding or valuation changes

Explore More Data

Detailed analysis for TARA Biosystems

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock TARA Biosystems's valuation history, funding rounds, and growth metrics.

No credit card required

What is TARA Biosystems Worth in 2026?

TARA Biosystems is a leading private company in the Drug Discovery sector. Track TARA Biosystems's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How TARA Biosystems Valuation is Determined

Private company valuations like TARA Biosystems's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.